Design of a small-molecule entry inhibitor with activity against primary measles virus strains

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3755-3761

  Plemper, Richard K ^a   Doyle, Joshua ^a   Sun, Aiming ^b   Prussia, Andrew ^b   Cheng, Li Ting ^a   Rota, Paul A ^c   Liotta, Dennis C ^b   Snyder, James P ^b   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; SMALL MOLECULE TRANSPORT AGENT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DEVELOPING COUNTRY; DRUG HALF LIFE; DRUG STABILITY; ENDEMIC DISEASE; INCIDENCE; MEASLES VIRUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STRAIN DIFFERENCE; VACCINATION; VIRUS INFECTION; VIRUS STRAIN;

AMINOPHENOLS; ANIMALS; ANTIVIRAL AGENTS; BENZENEACETAMIDES; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG STABILITY; HUMANS; MEASLES VIRUS; RNA, VIRAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; VERO CELLS;

EID: 24144473658     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3755-3761.2005     Document Type: Article

References (38)

1. Centers for Disease Control and Prevention. 2005. Progress in reducing measles mortality - worldwide, 1999-2003. Morb. Mortal. Wkly. Rep. 54:200-203.
2. Cianci, C., D. R. Langley, D. D. Dischino, Y. Sun, K. L. Yu, A. Stanley, J. Roach, Z. Li, R. Dalterio, R. Colonno, N. A. Meanwell, and M. Krystal. 2004. Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion. Proc. Natl. Acad. Sci. USA 101:15046-15051.
3. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305.
4. Gans, H. A., A. M. Arvin, J. Galinus, L. Logan, R. DeHovitz, and Y. Maldonado. 1998. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280:527-532.
5. Garrett, R. H., and C. M. Grisham. 2005. Biochemistry, 3rd ed. Thomson Learning, Inc., Stamford, Conn.
6. Hilleman, M. R. 2001. Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine 20:651-665.
7. Jang, M., L. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. Beecher, H. H. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, R. C. Moon, and J. M. Pezzuto. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220.
8. Jansen, V. A., N. Stollenwerk, H. J. Jensen, M. E. Ramsay, W. J. Edmunds, and C. J. Rhodes. 2003. Measles outbreaks in a population with declining vaccine uptake. Science 301:804.
9. Kaya, I. 2004. Synthesis, characterization, and optimum reaction conditions of oligo-benzylidene-3′-hydroxyaniline. Int. J. Polymer Anal. Charact. 9:137-151.
10. Kizhatil, K., and L. M. Albritton. 1997. Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J. Virol. 71:7145-7156.
11. Lamb, R. A. 1993. Paramyxovirus fusion: a hypothesis for changes. Virology 197:1-11.
12. Lamb, R. A., and D. Kolakosky. 1996. Paramyxoviridae: the viruses and their replication, p. 1305-1340. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
13. Lambert, D. M., S. Barney, A. L. Lambert, K. Guthrie, R. Medinas, D. E. Davis, T. Bucy, J. Erickson, G. Merutka, and S. R. Petteway, Jr. 1996. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93:2186-2191.
14. Longini, I. M., Jr., M. E. Halloran, A. Nizam, and Y. Yang. 2004. Containing pandemic influenza with antiviral agents. Am. J. Epidemiol. 159:623-633.
15. Mossong, J., D. J. Nokes, W. J. Edmunds, M. J. Cox, S. Ratnam, and C. P. Muller. 1999. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am. J. Epidemiol. 150:1238-1249.
16. Mossong, J., C. J. O'Callaghan, and S. Ratnam. 2000. Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population. Vaccine 19:523-529.
17. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
18. Norrby, E. 1971. The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology 44:599-608.
19. Oldstone, M. B., D. Homann, H. Lewicki, and D. Stevenson. 2002. One, two, or three step: measles virus receptor dance. Virology 299:162-163.
20. Plemper, R. K., and R. W. Compans. 2003. Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J. Virol. 77:4181-4190.
21. Plemper, R. K., K. J. Erlandson, A. S. Lakdawala, A. Sun, A. Prussia, J. Boonsombat, E. Aki-Sener, I. Yalcin, I. Yildiz, O. Temiz-Arpaci, B. Tekiner, D. C. Liotta, J. P. Snyder, and R. W. Compans. 2004. A target site for template-based design of measles virus entry inhibitors. Proc. Natl. Acad. Sci. USA 101:5628-5633.
22. Plemper, R. K., A. L. Hammond, and R. Cattaneo. 2000. Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J. Virol. 74:6485-6493.
23. Plemper, R. K., A. L. Hammond, and R. Cattaneo. 2001. Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J. Biol. Chem. 276:44239-44246.
24. Plemper, R. K., A. L. Hammond, D. Gerlier, A. K. Fielding, and R. Cattaneo. 2002. Strength of envelope protein interaction modulates cytopathicity of measles virus. J. Virol. 76:5051-5061.
25. Plemper, R. K., A. S. Lakdawala, K. M. Gernert, J. P. Snyder, and R. W. Compans. 2003. Structural features of paramyxovirus F protein required for fusion initiation. Biochemistry 42:6645-6655.
26. Polack, F. P., S. H. Lee, S. Permar, E. Manyara, H. G. Nousari, Y. Jeng, F. Mustafa, A. Valsamakis, R. J. Adams, H. L. Robinson, and D. E. Griffin. 2000. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat. Med. 6:776-781.
27. Putz, M. M., F. B. Bouche, R. L. de Swart, and C. P. Muller. 2003. Experimental vaccines against measles in a world of changing epidemiology. Int. J. Parasitol. 33:525-545.
28. Rapaport, D., M. Ovadia, and Y. Shai. 1995. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. EMBO J. 14:5524-5531.
29. Roche, M., C. Dufour, N. Mora, and O. Dangles. 2005. Antioxidant activity of olive phenols: mechanistic investigation and characterization of oxidation products by mass spectrometry. Org. Biomol. Chem. 3:423-430.
30. Rota, P. A., and W. J. Bellini. 2003. Update on the global distribution of genotypes of wild type measles viruses. J. Infect. Dis. 187(Suppl. 1):S270-S276.
31. Starr-Spires, L. D., and R. G. Collman. 2002. HIV-1 entry and entry inhibitors as therapeutic agents. Clin. Lab. Med. 22:681-701.
32. Tatsuo, H., N. Ono, K. Tanaka, and Y. Yanagi. 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897.
33. Tatsuo, H., N. Ono, and Y. Yanagi. 2001. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J. Virol. 75:5842-5850.
34. Vinson, J. A., X. Su, L. Zubik, and P. Bose. 2001. Phenol antioxidant quantity and quality in foods: fruits. J. Agric. Food Chem. 49:5315-5321.
35. Weiss, W. J., T. Murphy, M. E. Lynch, J. Frye, A. Buklan, B. Gray, E. Lenoy, S. Mitelman, J. O'Connell, S. Quartuccio, and C. Huntley. 2003. Inhalation efficacy of RFI-641 in an African green monkey model of RSV infection. J. Med. Primatol. 32:82-88.
36. Yan, X., B. T. Murphy, G. B. Hammond, J. A. Vinson, and C. C. Neto. 2002. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J. Agric. Food Chem. 50:5844-5849.
37. Yao, Q., and R. W. Compans. 1996. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223:103-112.
38. Young, J. K., R. P. Hicks, G. E. Wright, and T. G. Morrison. 1997. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology 238:291-304.